🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

Based on TikTok, the platform has removed problematic content and banned related hashtags and search suggestions. The organization stated it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of weight loss, glowing reviews and detailed guides for mixing or administering at residence.

Within moments of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Product Details and Pricing

Within these communities, messages display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a injector should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to possibly serious medical dangers”.